Special Emphasis Panel for Cancer Therapeutics R21 – TCO81
This study section reviews applications in the areas of patient-oriented research and clinical therapeutic trials. This includes clinical trials with therapeutic intent using drugs, radiation, surgery, biological factors, and chemopreventive agents.
Review Dates
A roster for the panel will be posted here, at least 30 days prior to the review meeting
Topics
- Pilot or early phase I trials including surgery, chemotherapy, radiation therapy, and combination therapies
- Treatment modalities include chemopreventive agents, gene therapy, and small drug molecules for targeted therapy
- Correlative studies relevant to therapeutic clinical trials
- Pharmacologic and toxicological studies of new modalities in large animal models and patients
